BCMA/CD19 CAR T cells clinical trials

A New Study Evaluating the Activity of Modular CAR T for mYeloma

This study looks at a new cell therapy called CAR T for multiple myeloma that has come back or isn't responding to treatment. We want to see if it's safe and how well it works. It uses specially changed white blood cells to fight the cancer.